News & Press Coverage
December 13, 2021
Congratulations to Lena Gamboa for defending her Ph.D. thesis! Lena received glowing remarks from her committee after defending her thesis, titled "Programming synthetic T cell immunity against solid tumors," on December 13, 2021. We look forward to your future success!
October 22, 2021
Glympse Bio’s work on multiplexed protease sensors for urinary monitoring of nonalcoholic steatohepatitis was published in Science Translational Medicine! Congratulations to Gabe and the team! Read the full manuscript here. Summary | Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease that has been dubbed the silent epidemic as it has few symptoms. When […]
October 6, 2021
Congratulations to these students who presented their work at the 2021 BMES Annual Meeting in Orlando, Florida: Ida Su – “In situ programming of virus-specific T cells for CAR T cell therapy” Lena Gamboa – “Sensitizing Solid tumors to T cell Mediated Immunity Using Synthetic Antigens as CAR Targets” Ali Zamat – “Thermal Control of […]
- September 23, 2021
September 8, 2021
Zizhen "Jane" Zha joins LSI as a new graduate student. Jane completed her bachelors at Washington University in St. Louis in BME and minored in Computer Science. Jane worked in Dr. Lori Setton's lab as an undergraduate and later post-bac researcher, receiving the BioSURF fellowship along the way. Read more about Jane here.
September 6, 2021
Our review entitled “Synthetic biomarkers: a twenty-first century path to early cancer detection” was published in Nature Reviews Cancer! Congratulations to Gabe and the team! Read the full manuscript here. Summary | In 2019, the NCI Division of Cancer Prevention co-organized a think tank meeting on synthetic biomarkers for early detection. We wrote this review […]
August 17, 2021
A team of researchers led by bioengineers at the Georgia Institute of Technology is expanding the precision and ability of a revolutionary immunotherapy that is already transforming oncology. CAR T-Cell therapy has been hailed by patients, clinical-researchers, investors, and the media as a viable cure for some cancers. CAR T-Cell therapy involves engineering a patient’s […]
August 13, 2021
Congratulations to Quoc Mac for completing his Ph.D.! Quoc will be working as a Research Scientist for Takeda in Cambridge, MA. LSI wishes you best of luck!
August 12, 2021
Our work on engineering CAR T cells to turn on and fight cancer in response to localized heat was published in Nature Biomedical Engineering! Congratulations to Ian, Ali, and the team! Read the full manuscript here. Summary | Treating solid tumors with chimeric antigen receptor (CAR) T cells typically results in poor responses. In this […]
June 3, 2021
Dr. Kwong was among five faculty members to receive a distinguished fellowship from the Wallace H. Coulter Department of Biomedical Engineering this spring. He was recognized for his “ongoing and outstanding impactful contributions […] to Coulter BME – and the biomedical engineering profession, writ large.” Read more here.
April 22, 2021
Our review on biomaterials that interface with synthetic immunity to improve engineered T cell therapies is published in Advanced Healthcare Materials! Congrats to Ida, Quoc, and the team! Read the manuscript here.
March 18, 2021
Our work on synthetic antigen-presenting cells for antigen-specific activation of T cells was published in Advanced Therapeutics! Congratulations to Shreyas, Anna, and the team! Read the full manuscript here.
March 9, 2021
Congratulations to Quoc Mac for defending his Ph.D. thesis! Quoc successfully defended his thesis, titled "Engineered activity sensors for predictive immune monitoring," in front of a virtual crowd on March 9, 2021. We look forward to your future success!
January 28, 2021
Students in Dr. Gabe Kwong’s BMED 3310: Biotransport course rated him as one of the best instructors at Georgia Tech for 2020! He is among ten faculty members in the Wallace H. Coulter Department of Biomedical Engineering to make Georgia Tech’s first-ever teaching honor roll. Read more here.